Education
About Us
Working with TipRanks
Follow Us
Nova Eye Medical (AU:EYE)
ASX:EYE
Total Valuation
Nova Eye Medical has a market cap or net worth of $36.94M. The enterprise value is ―.
Market Cap$36.94M
Enterprise Value―
Share Statistics
Nova Eye Medical has 284,146,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding284,146,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nova Eye Medical’s return on equity (ROE) is -0.41 and return on invested capital (ROIC) is -36.34%.
Return on Equity (ROE)-0.41
Return on Assets (ROA)-0.29
Return on Invested Capital (ROIC)-36.34%
Return on Capital Employed (ROCE)-0.37
Revenue Per Employee77.49K
Profits Per Employee-29.20K
Employee Count301
Asset Turnover0.78
Inventory Turnover0.73
Valuation Ratios
The current PE Ratio of Nova Eye Medical is -4.99. Nova Eye Medical’s PEG ratio is -0.29.
PE Ratio-4.99
PS Ratio0.00
PB Ratio1.72
Price to Fair Value2.06
Price to FCF-4.97
Price to Operating Cash Flow-4.08
PEG Ratio-0.29
Income Statement
In the last 12 months, Nova Eye Medical had revenue of 23.32M and earned -8.79M in profits. Earnings per share was -0.04.
Revenue23.32M
Gross Profit20.19M
Operating Income-8.97M
Pretax Income-8.79M
Net Income-8.79M
EBITDA-5.98M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -7.32M and capital expenditures -110.00K, giving a free cash flow of -7.42M billion.
Operating Cash Flow-7.32M
Free Cash Flow-7.42M
Free Cash Flow per Share-0.03
Dividends & Yields
Nova Eye Medical pays an annual dividend of AU$0.135, resulting in a dividend yield of ―
Dividend Per ShareAU$0.135
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.34
52-Week Price Change-55.56%
50-Day Moving Average0.11
200-Day Moving Average0.15
Relative Strength Index (RSI)64.69
Average Volume (3m)341.47K
Important Dates
Nova Eye Medical upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateFeb 25, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend DateJul 21, 2020
Financial Position
Nova Eye Medical as a current ratio of 2.60, with Debt / Equity ratio of 19.43%
Current Ratio2.60
Quick Ratio1.84
Debt to Market Cap0.00
Net Debt to EBITDA0.47
Interest Coverage Ratio-128.11
Taxes
In the past 12 months, Nova Eye Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Nova Eye Medical EV to EBITDA ratio is -6.87, with an EV/FCF ratio of -4.95.
EV to Sales1.76
EV to EBITDA-6.87
EV to Free Cash Flow-4.95
EV to Operating Cash Flow-5.23
Balance Sheet
Nova Eye Medical has $2.26M in cash and marketable securities with AU$3.38M in debt, giving a net cash position of $1.12M billion.
Cash & Marketable Securities$2.26M
Total DebtAU$3.38M
Net Cash$1.12M
Net Cash Per Share<$0.01
Tangible Book Value Per Share$0.07
Margins
Gross margin is 75.89%, with operating margin of -38.45%, and net profit margin of -37.68%.
Gross Margin75.89%
Operating Margin-38.45%
Pretax Margin-37.68%
Net Profit Margin-37.68%
EBITDA Margin-25.63%
EBIT Margin-38.45%
Analyst Forecast
The average price target for Nova Eye Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast39.08%
EPS Growth Forecast53.31%